Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 14, 2026; 32(30): 117778
Published online Aug 14, 2026. doi: 10.3748/wjg.117778
Published online Aug 14, 2026. doi: 10.3748/wjg.117778
Table 3 Multivariable analysis for relapse-free survival
| Multivariable model | ||
| HR (95%CI) | P value | |
| cT | ||
| 2-3 | 1.00 | |
| 4 | 1.92 (1.03-3.56) | 0.038 |
| Response to treatment (Becker + lymph nodes) | ||
| Poor response | 1.00 | |
| Good response | 0.36 (0.15-0.85) | 0.020 |
| Lauren histotype (main effect) | ||
| Diffuse | 1.00 | |
| Intestinal | 1.26 (0.44-3.64) | 0.665 |
| Other | 0.54 (0.15-1.90) | 0.335 |
| Lauren histotype (time-dependent effect) | ||
| Diffuse | 1.00 | |
| Intestinal | 0.95 (0.91-0.99) | 0.034 |
| Other | 1.01 (0.98-1.04) | 0.462 |
- Citation: Monti M, Ceredi B, Foca F, Morgagni P, Framarini M, Vertogen B, Marrelli D, Roviello F, Fumagalli Romario U, Bozzarelli S, Donini A, Graziosi L, Filippini F, Bencivenga M, Milandri C, Mura G, Baiocchi GL, Rausei S, Molinari C, Passardi A. When and where: A study on gastric cancer recurrence after neoadjuvant/perioperative chemotherapy. World J Gastroenterol 2026; 32(30): 117778
- URL: https://www.wjgnet.com/1007-9327/full/v32/i30/117778.htm
- DOI: https://dx.doi.org/10.3748/wjg.117778